Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Shares Outstanding (Weighted Average): 2011-2024

Historic Shares Outstanding (Weighted Average) for RedHill Biopharma (RDHL) over the last 13 years, with Dec 2024 value amounting to $12.7 billion.

  • RedHill Biopharma's Shares Outstanding (Weighted Average) rose 1.20% to $12.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $12.9 billion, marking a year-over-year increase of 1.20%. This contributed to the annual value of $12.7 billion for FY2024, which is 897.46% up from last year.
  • Per RedHill Biopharma's latest filing, its Shares Outstanding (Weighted Average) stood at $12.7 billion for FY2024, which was up 897.46% from $1.3 billion recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) registered a high of $12.7 billion during FY2024, and its lowest value of $352.7 million during FY2020.
  • Over the past 3 years, RedHill Biopharma's median Shares Outstanding (Weighted Average) value was $1.3 billion (recorded in 2023), while the average stood at $4.9 billion.
  • Data for RedHill Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY soared of 897.46% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows RedHill Biopharma's Shares Outstanding (Weighted Average) stood at $352.7 million in 2020, then surged by 32.67% to $467.9 million in 2021, then soared by 36.43% to $638.4 million in 2022, then spiked by 100.19% to $1.3 billion in 2023, then skyrocketed by 897.46% to $12.7 billion in 2024.